Your session is about to expire
← Back to Search
Behavioral Intervention
Telementoring for Cancer Survivorship Care (KANSURVIVE Trial)
N/A
Waitlist Available
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Must be capable and willing to complete pre- and post- data collection
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 month
Awards & highlights
KANSURVIVE Trial Summary
This trial will help identify how to better provide cancer survivorship care in rural areas.
Who is the study for?
The KanSurvive trial is for rural primary care practices in Kansas that are willing to improve cancer survivorship care. They must participate in four telementoring sessions and complete data collection before and after the intervention.Check my eligibility
What is being tested?
This study tests a new model called KanSurvive-ECHO, aimed at enhancing cancer care after treatment. It involves evaluating work flows, training through ECHO sessions, and assessing the model's effectiveness in improving survivorship care.See study design
What are the potential side effects?
Since this trial focuses on educational interventions rather than medical treatments, traditional side effects are not applicable. However, there may be challenges related to changes in practice workflow or adoption of new procedures.
KANSURVIVE Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am willing and able to provide information before and after the trial.
KANSURVIVE Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 month
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 month
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Percent change in evidence based cancer screening
Other outcome measures
Participation rates in the Telementoring and Practice Facilitation Sessions
KANSURVIVE Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: cluster-randomized controlled trial, interventionExperimental Treatment1 Intervention
Intervention arm
Group II: cluster-randomized controlled trial, with delayed start control armActive Control1 Intervention
Control arm/Delayed Onset
Find a Location
Who is running the clinical trial?
University of Kansas Medical CenterLead Sponsor
458 Previous Clinical Trials
168,688 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,621 Previous Clinical Trials
40,927,022 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am willing and able to provide information before and after the trial.
Research Study Groups:
This trial has the following groups:- Group 1: cluster-randomized controlled trial, with delayed start control arm
- Group 2: cluster-randomized controlled trial, intervention
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this research endeavor actively seeking participants?
"Correct. According to the clinicaltrials.gov portal, this medical trial is currently enrolling patients who first posted on November 18th 2020. The most recent update was published February 18th 2021 and 20 participants need to be recruited at a single site."
Answered by AI
How many participants are in this clinical trial?
"Affirmative. Clinicaltrials.gov data highlights that, beginning on November 18th 2020, this clinical trial is presently accepting enrolment applications. 20 patients are sought from a single participating site."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger